Common genetic variation in loci encoding for FGFR2 and MAP3K1 influences risk of breast cancer [2], [4], and these genes were previously found to be somatically mutated in diverse neoplasias including breast cancer [10], [11]. This evidence concerns the gene MAP3K1 and breast cancer.